FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

23 January 2020 - Today, the U.S. Food and Drug Administration granted accelerated approval to Tazverik (tazemetostat) for the treatment of ...

Read more →

ICER releases draft evidence report on therapies for sickle cell disease

23 January 2020 - ICER’s ongoing assessment emphasises that policy makers will need to consider, in addition to traditional measures ...

Read more →

The intricacies of rising drug prices in the US

23 January 2020 - Following 250 US drug price increases in 2020 already, this article explores why costs are rising, what ...

Read more →

Want to know how contentious drug pricing is in Washington? Check the receipts.

23 January 2020 - Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that belong to the ...

Read more →

Baudax Bio announces PDUFA date for intravenous meloxicam

22 January 2020 - Baudax Bio today announced that the U.S. FDA has set a PDUFA goal date of 20 ...

Read more →

Sick of high drug prices, insurers join hospitals to make their own generic medications

23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...

Read more →

Jazz Pharmaceuticals submits new drug application for JZP-258 for cataplexy and excessive daytime sleepiness associated with narcolepsy

22 January 2020 - Jazz Pharmaceuticals today announced the submission of a new drug application to the U.S. Food and Drug ...

Read more →

Supernus announces FDA acceptance for review of new drug application for SPN-812 for the treatment of ADHD

21 January 2020 - PN-812 (viloxazine hydrochloride), a once-daily novel serotonin norepinephrine modulating agent, demonstrates a reduction in ADHD-RS-5 total score ...

Read more →

The FDA continues to struggle with the implications of approving Sarepta’s drugs

22 January 2020 - New documents released Wednesday lay bare the stark divide within the Food and Drug Administration regarding ...

Read more →

Competition, not capping increases, is the cure for high drug prices

22 January 2020 - Soaring prescription drug prices are putting financial pressure on families across the country.  ...

Read more →

Supreme Court refuses to fast-track a challenge to the Affordable Care Act

22 January 2020 - The Supreme Court on Tuesday denied a motion to fast-track a challenge to the Affordable Care ...

Read more →

FDA accepts Evoke Pharma’s NDA resubmission for Gimoti

21 January 2020 - PDUFA Target Goal Date is 19 June 2020. ...

Read more →

FDA approves first treatment for thyroid eye disease

21 January 2020 - Today, the U.S. FDA approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a ...

Read more →

Old drug, new tricks: existing medicines show promise in fighting cancer

20 January 2020 - Dozens of compounds approved for other purposes can kill cancer cells selectively. ...

Read more →

Genprex receives U.S. FDA fast track designation for gene therapy that targets lung cancer

21 January 2020 - Genprex today announced that the U.S FDA has granted fast track Designation for Genprex’s Oncoprex immunogene ...

Read more →